摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-甲基-1(2H)-异喹啉酮 | 131002-10-3

中文名称
6-甲基-1(2H)-异喹啉酮
中文别名
6-甲基异喹啉-1(2H)-酮;1-羟基-6-甲基异喹啉
英文名称
6-methylisoquinolin-1(2H)-one
英文别名
6-methyl-2H-isoquinolin-1-one
6-甲基-1(2H)-异喹啉酮化学式
CAS
131002-10-3
化学式
C10H9NO
mdl
MFCD13190254
分子量
159.188
InChiKey
AVBPTIYKXNVKNJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    393.9±42.0 °C(Predicted)
  • 密度:
    1.150±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933790090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温、密封、干燥

SDS

SDS:7a391c22482e525b930880846b08b83c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-甲基-1(2H)-异喹啉酮吡啶甲醇4-二甲氨基吡啶sodium methylate四氯化锡三乙胺 作用下, 以 二氯甲烷乙腈 为溶剂, 反应 1.75h, 生成
    参考文献:
    名称:
    Efforts toward Expansion of the Genetic Alphabet:  Optimization of Interbase Hydrophobic Interactions
    摘要:
    Six novel unnatural nucleobases have been characterized that form stable base pairs in duplex DNA, relying nor on hydrogen bonds, but rather on interbase hydrophobic interactions. These nucleobases are derivatives of the hydrophobic base pair between 7-azaindole (7AI) and isocarbostyril (ICS). Derivatives of 7AI and ICS were examined that have increased hydrophobic surface area, as well as increased polarizability. As observed with 7AI and ICS, these derivatives are recognized as substrates by Klenow fragment of Escherichia coli DNA polymerase I. The unnatural base pair between pyrrolopyrizine (PP) and C3-methylisocarbostyril (MICS) is enzymatically incorporated into DNA with high efficiency (k(cat)/K-M = 10(6) M-1 min(-1)) and moderate selectivity. These studies represent a significant step toward the generation of astable, orthogonal base pair that can be enzymatically incorporated into DNA with good fidelity.
    DOI:
    10.1021/ja0009931
  • 作为产物:
    描述:
    参考文献:
    名称:
    含新型P1针作为TF / VIIa抑制剂的吡嗪酮的设计,合成和生物学评估。
    摘要:
    本文描述了一系列取代的吡嗪酮作为TF / VIIa复合物抑制剂的设计,合成和酶促活性。设计这些抑制剂以探索先前描述的P1 idine的置换和变异[J. 中 Chem.2003,46,4050]。根据与母体苯基am(pKa约为12)相比降低的碱性,选择P1针头替代品。影响化合物口服生物利用度的一个因素是该化合物在肠道中的电离状态。该研究的理想结果是确定一种口服生物利用的TF-VIIa抑制剂。
    DOI:
    10.1016/j.bmcl.2007.05.090
点击查看最新优质反应信息

文献信息

  • [EN] HEPATITIS C VIRUS INHIBITORS<br/>[FR] INHIBITEURS DU VIRUS DE L'HEPATITE C
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2003099274A1
    公开(公告)日:2003-12-04
    Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.
    丙型肝炎病毒抑制剂公开了具有以下通式:其中R1、R2、R3、R'、B、Y和X在描述中有所描述。还公开了包含该化合物的组合物以及使用该化合物抑制HCV的方法。
  • HSP90 INHIBITING INDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF
    申请人:Bertin Luc
    公开号:US20120010241A1
    公开(公告)日:2012-01-12
    The invention relates to novel products having formula (I), wherein: R4 represents H, CH3, CH2CH3, CF3, F, Cl, Br, I; Het represents a heterocycle optionally substituted by one or more R1 or R′1 radicals selected from H, halogen, CF3, nitro, cyano, alkyl, hydroxy, mercapto, amino, alkylamino, dialkylamino, alkoxy, phenylalkoxy, alkylthio, carboxy that is free or sterified with an alkyl radical, carboxamide, CO—NH(alkyl), CON(alkyl)2, NH—CO-alkyl, sulfonamide, NH—SO2-alkyl, S(O)2-NHalkyl, S(O2)-N(alkyl)2, all of the alkyl, alkoxy and alkylthio radicals being optionally substituted; R being selected from the group comprising (A′), (B), (C), (D) and (F), wherein W1, W2, W3 represent independently CH or N, X represents O, S, NR2, C(O), S(O) or S(O)2; V represents H, Hal, —O—R2 or —NH—R2 with R2 representing H, alkyl, cycloalkyl or heterocycloalkyl, optionally substituted; said products being in all isomer forms, as well as the salts and intended for use as drugs.
    本发明涉及具有公式(I)的新产品,其中:R4代表H,CH3,CH2CH3,CF3,F,Cl,Br,I;Het代表一个杂环,可选地由一个或多个R1或R'1自由基取代,这些自由基选自H,卤素,CF3,硝基,腈基,烷基,羟基,巯基,氨基,烷基氨基,二烷基氨基,烷氧基,苯基烷氧基,烷基硫醚,游离或与烷基自由基酯化的羧基,羧酰胺,CO—NH(烷基),CON(烷基)2,NH—CO-烷基,磺酰胺,NH—SO2-烷基,S(O)2-NH烷基,S(O2)-N(烷基)2,所有烷基,烷氧基和烷基硫醚自由基都是可选取代的;R选自包括(A′),(B),(C),(D)和(F)的组,其中W1,W2,W3独立代表CH或N,X代表O,S,NR2,C(O),S(O)或S(O)2;V代表H,Hal,—O—R2或—NH—R2,R2代表H,烷基,环烷基或杂环烷基,可选取代;所述产品为所有异构体形式,以及盐,用于作为药物使用。
  • [EN] QUINOLONE COMPOUND<br/>[FR] COMPOSÉ QUINOLONE
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2013029548A1
    公开(公告)日:2013-03-07
    The present invention provides a compound represented by the formula (I) wherein X is a hydrogen atom or a fluorine atom; R is a hydrogen atom or alkyl; R1 is (1) cyclopropyl optionally substituted by to 3 halogen atoms or (2) phenyl optionally substituted by 1 to 3 halogen atoms; R2 is alkyl, alkoxy, haloalkoxy, a halogen atom, cyano, etc.; and R3 is 7-oxo-7,8-dihydro-1,8-naphthyridinyl, 3-pyridyl, etc., or a salt thereof. The compound of the present invention has excellent antimicrobial activity against Clostridium difficile and is useful for the prevention or treatment of intestinal infection such as Clostridium difficile- associated diarrhea.
    本发明提供了一种化合物,其表示为式(I),其中X为氢原子或氟原子;R为氢原子或烷基;R1为(1)环丙基,可选择地被1至3个卤原子取代,或(2)苯基,可选择地被1至3个卤原子取代;R2为烷基、烷氧基、卤代烷氧基、卤原子、氰基等;R3为7-氧代-7,8-二氢-1,8-萘啶基,3-吡啶基等,或其盐。本发明的化合物对厌氧菌艰难梭菌具有优异的抗菌活性,并可用于预防或治疗肠道感染,如厌氧菌艰难梭菌相关性腹泻。
  • [EN] COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR LE TRAITEMENT DE MALADIES PARASITAIRES
    申请人:IRM LLC
    公开号:WO2014078813A1
    公开(公告)日:2014-05-22
    The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease, such as malaria, caused by a Plasmodium parasite.
    本发明提供了式I的化合物:[在此插入公式]或其药学上可接受的盐、互变异构体或立体异构体,其中变量如本文所定义。本发明还提供了包含这种化合物的药物组合物以及使用这种化合物治疗、预防、抑制、改善或根除由疟原虫引起的疟疾等疾病的方法。
  • Divergent Synthesis of Isoquinolone and Isocoumarin Derivatives by the Annulation of Benzoic Acid with <i>N</i>-Vinyl Amide
    作者:Rui Sun、Xiao Yang、Qianggen Li、Ke Xu、Juan Tang、Xueli Zheng、Maolin Yuan、Haiyan Fu、Ruixiang Li、Hua Chen
    DOI:10.1021/acs.orglett.9b03638
    日期:2019.12.6
    A simple and efficient method for the synthesis of isoquinolone and isocoumarin derivatives is reported. The method for the first time provides a one-step divergent synthesis of important isoquinolone and isocoumarin skeletons from benzoic acid by switching the coupling partners. In addition, a reliable mechanism has been proposed on the basis of experimental investigations, including kinetic isotope
    报道了一种简单有效的合成异喹诺酮和异香豆素衍生物的方法。该方法首次通过切换偶联伙伴,从苯甲酸一步一步地合成了重要的异喹诺酮和异香豆素骨架。此外,在实验研究的基础上,提出了一种可靠的机制,包括动力学同位素效应实验,13C标记实验,时间跟踪实验和竞争实验,以及DFT计算研究。
查看更多